Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29 CL.19A

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3579-3583

  Battu, Serge ^a   Rigaud, Michel ^a   Beneytout, Jean Louis ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Apoptosis colrectal cancer; Cyclooxygenase 2; HT29 cl.19A

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CYCLOOXYGENASE 2; DNA FRAGMENT;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HT29; CELL STRUCTURE; CHROMATIN; FETAL CALF SERUM; GENOME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; CATTLE; CELL DIVISION; CYCLOOXYGENASE 2; DINOPROSTONE; DNA FRAGMENTATION; HT29 CELLS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SERUM ALBUMIN, BOVINE;

EID: 0031789369     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer Statistics. CA Cancer J Clin 65: 5-27, 1996.
2. Thun MJ: Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev 13: 269-277, 1994.
3. Giovannucci E, Rimm EB, Stampfer MJ, Golditz GA, Ascherio A and Willett WC: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-246, 1994.
4. Smith WL and DeWitt DL: Prostaglandin endoperoxyde H synthase-1 and -2. Adv Immunol 62: 167-215, 1996.
5. Gustavson-Svard C, Lilja I, Hallbook O and Sjodahl R: Cyclooxygenase- 1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and azoxymethane induced colonic tumors in rats. Gut 38: 79-84, 1996.
6. Eberhart CE, Coffey RJ, Rahdika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
7. Kargman ST, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559, 1995.
8. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kalo H, Kondo M and Hla T: Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789, 1995.
9. DuBois RN, Rahdika A, Reddy BS and Entingh A: Increased cyclooxygenase-2 levels in carcinogen-induced rat colonie tumors. Gastroenterology 110: 1259-1262, 1996.
10. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL and Prescott SM: Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci USA 93: 4816-4820, 1996.
11. Tsujii M and DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
12. DuBois RN, Shao J, Tsujii M, Sheng H and Beauchamp RD: G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 56: 733-737, 1996.
13. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997.
14. Battu S, Chable-Rabinovitch H, Rigaud M and Beneytout J.L: Cyclooxygenase-2 expression in human adenocarcinoma cell line HT29 cl.19A. Anticancer Res. (in press), 1998.
15. Battu S, Clement G, Heyman M, Wal JM, Cook-Moreau J, Desjeux JF and Beneylout JL: Production of arachidonic acid metabolites by the colon adenocarcinoma cell line HT29 cl.19A and their effect on chloride secretion. Cancer Lett 116: 213-223, 1997.
16. Augeron C and Laboisse CL: Emergence of permanently differentiated cell clones in a human colonie cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44: 3961-3969, 1984.
17. Huang XP, Fan XT, Desjeux JF and Castagna M: Bile acids, non-phorbol-ester-type-tumor promotors, stimulated the phosphorylation of protein-kinase-C substrate in human platelets and colon cell line HT29. Int J Cancer 52: 444-450, 1992.
18. Tazawa R, Xu XM, Wu KK and Wang LH: Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun 203: 190-199, 1994.
19. Chen TR: In-situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104: 255-262, 1977.
20. Jeppesen C and Nielsen PE: Photofootprinting of drug-binding sites on DNA using diazo- and azido-9-aminoacridine derivatives. Eur J Biochem 182: 437-444, 1989.
21. Cohen JJ: Apoptosis. Immunol Today 14: 126-130, 1993.
22. Nunez G and Clarke MF: The Bel-2 family of proteins: regulators of cell death and survival. Trends in Cell biology 4: 399-403, 1994.
23. Schwartzman RA and Cidlowski JA: Apoptosis. The biochemistry and molecular biology of programmed cell death. Endocrine Rev 14: 133-152, 1993.
24. Prescott SM, White RL: Self promotion? Intimate connection between APC and prostaglandin H synthase-2. Cell 87: 783-786, 1996.
25. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD and Dubois RN-Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259, 1997.
26. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87: 803-809, 1996.